Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

SLS

SELLAS Life Sciences Group Inc

May 08 • 04:00PM ET

5.01

+0.08 1.62 %

Healthcare • Biotechnology • USA • Small • NASD

Peers: XNCR RCUS FATE KURA ADCT

| Held by: XBI VTI IWM VXF IWO VTWO VFMO IWC PTH LABU

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-0.25	Insider Own	1.27%	Shs Outstand	179.58M	Perf Week	1.62%
Market Cap	899.71M	Forward P/E	-	EPS next Y	-0.16	Insider Trans	2.86%	Shs Float	177.31M	Perf Month	-0.79%
Enterprise Value	828.82M	PEG	-	EPS next Q	-0.06	Inst Own	24.50%	Short Float	31.95%	Perf Quarter	34.32%
Income	-26.86M	P/S	-	EPS this Y	-12.00%	Inst Trans	2.62%	Short Ratio	9.28	Perf Half Y	198.21%
Sales	0.00M	P/B	10.82	EPS next Y	42.86%	ROA	-54.84%	Short Interest	56.64M	Perf YTD	32.89%
Book/sh	0.46	P/C	12.52	EPS next 5Y	-	ROE	-66.88%	52W High	6.14 -18.40%	Perf Year	198.21%
Cash/sh	0.40	P/FCF	-	EPS past 3/5Y	51.28% 34.92%	ROIC	-37.66%	52W Low	1.36 268.38%	Perf 3Y	178.33%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	5.05% 5.70%	Perf 5Y	-37.92%
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	54.32%	Oper. Margin	-	ATR (14)	0.32	Perf 10Y	-99.99%
Dividend Ex-Date	Mar 24, 2011	Quick Ratio	10.72	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	52.98	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	10.72	EPS Q/Q	45.12%	SMA20	2.38%	Beta	2.26	Target Price	10.00
Payout	-	Debt/Eq	0.01	Sales Q/Q	-	SMA50	1.07%	Rel Volume	0.56	Prev Close	4.93
Employees	13	LT Debt/Eq	0.01	Earnings	Mar 19 AMC	SMA200	64.29%	Avg Volume	6.10M	Price	5.01
IPO	Mar 12, 2008	Option/Short	Yes / Yes	EPS/Sales Surpr.	21.01% -	Trades		Volume	3,392,935	Change	1.62%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)